SCHEMBL16326257

SCHEMBL16326257

NCCCNC(=O)CC1CCCC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 3/20 0.55
NFE2L2 Q16236 3/20 0.55
EPHX2 P34913 1/20 0.50
HPGD P15428 2/20 0.47
EPHX1 P07099 1/20 0.47
KMT2A Q03164 1/20 0.47
CHRNB2 P17787 6/20 0.46
CHRNB4 P30926 6/20 0.46
CHRNA3 P32297 6/20 0.46
CHRNA4 P43681 6/20 0.46
GRIN1 Q05586 3/20 0.46
GRIN2A Q12879 3/20 0.46
GRM1 Q13255 3/20 0.46
RAB9A P51151 3/20 0.45
NPC1 O15118 2/20 0.45
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23016392 0.98 KEAP1 (0.57) KEAP1NFE2L2EPHX2HPGDEPHX1
SCHEMBL24340632 0.93 KEAP1 (0.60) KEAP1NFE2L2EPHX2HPGDEPHX1
SCHEMBL12954012 0.92 KEAP1 (0.46) KEAP1NFE2L2EPHX2CHRNB2CHRNB4
SCHEMBL9502456 0.92 CHRNB2 (0.56) KEAP1NFE2L2EPHX2CHRNB2CHRNB4
SCHEMBL15680573 0.88 KEAP1 (0.66) KEAP1NFE2L2EPHX2HPGDEPHX1
SCHEMBL5242576 0.84 HDAC3 (0.51) KEAP1NFE2L2EPHX2HPGDEPHX1
SCHEMBL7390370 0.81 KEAP1 (0.55) KEAP1NFE2L2EPHX2HPGDEPHX1
SCHEMBL6359085 0.81 KEAP1 (0.55) KEAP1NFE2L2EPHX2HPGDEPHX1
SCHEMBL24193476 0.80 KEAP1 (0.57) KEAP1NFE2L2EPHX2HPGDEPHX1
SCHEMBL628952 0.80 KEAP1 (0.57) KEAP1NFE2L2EPHX2HPGDEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016545-A1 PROCESS FOR THE COVALENT COUPLING OF TWO MOLECULES BY MEANS OF A DIELS-ALDER REACTION WITH INVERSE ELECTRON REQUIREMENT DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016545-A1 PROCESS FOR THE COVALENT COUPLING OF TWO MOLECULES BY MEANS OF A DIELS-ALDER REACTION WITH INVERSE ELECTRON REQUIREMENT CX3CR1, NR3C2, NR4A2 KEAP1 2129/4885NFE2L2 343/4885EPHX2 677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.